
Convergent Animal + Health (Convergent A+H) is an animal pathogen surveillance company developing diagnostics for livestock and wildlife pathogens and for the identification of pre-emergent zoonotic pathogens. Their proprietary, patent-pending miRNA biomarker tests aim to revolutionize animal health monitoring by enabling timely, cost-effective detection of pathogens before symptoms appear. They focus on livestock testing (e.g., parainfluenzas in cattle), wildlife surveillance (e.g., Chronic Wasting Disease in deer), and zoonotic pathogen identification. A strategic partner, Texas Tech University Health Sciences Center, received a $250,000 USDA grant to validate their miRNA test for CWD in deer. Founded in 2021, Convergent A+H leverages AI and ML algorithms for predictive insights and mitigation strategies.

Convergent Animal + Health (Convergent A+H) is an animal pathogen surveillance company developing diagnostics for livestock and wildlife pathogens and for the identification of pre-emergent zoonotic pathogens. Their proprietary, patent-pending miRNA biomarker tests aim to revolutionize animal health monitoring by enabling timely, cost-effective detection of pathogens before symptoms appear. They focus on livestock testing (e.g., parainfluenzas in cattle), wildlife surveillance (e.g., Chronic Wasting Disease in deer), and zoonotic pathogen identification. A strategic partner, Texas Tech University Health Sciences Center, received a $250,000 USDA grant to validate their miRNA test for CWD in deer. Founded in 2021, Convergent A+H leverages AI and ML algorithms for predictive insights and mitigation strategies.